tiprankstipranks
Genufood Energy Enzymes (GFOO)
OTHER OTC:GFOO
US Market

Genufood Energy Enzymes (GFOO) Stock Price & Analysis

16 Followers

GFOO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.03
Previous Close$0.01
Volume10.20K
Average Volume (3M)N/A
Market Cap
$4.29M
Enterprise Value$4.27M
Total Cash (Recent Filing)$19.62K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-12.0
Beta-0.38
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding808,900,041
10 Day Avg. Volume10,695
30 Day Avg. VolumeN/A
Standard Deviation2.41
R-Squared0.00014
Alpha0.45
Financial Highlights & Ratios
Price to Book (P/B)-66.51
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-9.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

11.85%0.00%0.00%88.15%
11.85%
Insiders
0.00%
Mutual Funds
0.00% Other Institutional Investors
88.15% Public Companies and
Individual Investors

GFOO FAQ

What was Genufood Energy Enzymes’s price range in the past 12 months?
Genufood Energy Enzymes lowest stock price was $0.00 and its highest was $0.03 in the past 12 months.
    What is Genufood Energy Enzymes’s market cap?
    Currently, no data Available
    When is Genufood Energy Enzymes’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Genufood Energy Enzymes’s earnings last quarter?
    Currently, no data Available
    Is Genufood Energy Enzymes overvalued?
    According to Wall Street analysts Genufood Energy Enzymes’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Genufood Energy Enzymes pay dividends?
      Genufood Energy Enzymes does not currently pay dividends.
      What is Genufood Energy Enzymes’s EPS estimate?
      Genufood Energy Enzymes’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Genufood Energy Enzymes have?
      Genufood Energy Enzymes has 808,900,000 shares outstanding.
        What happened to Genufood Energy Enzymes’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Genufood Energy Enzymes?
        Currently, no hedge funds are holding shares in GFOO
        ---

        Genufood Energy Enzymes Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        81.50%
        Trailing 12-Months

        Company Description

        Genufood Energy Enzymes

        Genufood Energy Enzymes Corp. is a development stage company, which markets, distributes and exports company specialized in enzyme products for human and animal consumption. Its trademark's include ProCellax and ProAnilax. The ProCellax range of enzyme products are pharmaceutical-grade enzyme supplements for digestive, colon health, cardiovascular, anti-inflammatory, and joint health. The ProAnilax range of enzyme products are a multi enzyme blend of non-animal source enzymes specially formulated for the digestive system of dogs and cats; and to facilitate movement as well as tissue and muscle healing thus helps repair damaged tissue. The company was founded on June 21, 2010 and is headquartered in Los Angeles, CA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Plug Power
        Ballard Power Systems
        Enphase Energy
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis